We are live on ! Find out more
GENE

Genetic Technologies Ltd.
GENE

Delisted

GENE was delisted on the 16th of October, 2024.

Back to rankings

6 hedge funds and large institutions have $189K invested in Genetic Technologies Ltd. in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

221% more capital invested

Capital invested by funds: $59K → $189K (+$130K)

0% more funds holding

Funds holding: 6 → 6 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$79.5K
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$20.9K
3
Morgan Stanley
Morgan Stanley
New York
+$460

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$6.38K
2
Wells Fargo
Wells Fargo
California
-$312

GENE Hedge Fund Activity: Q1 2024 in Review

6 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q1 2024, worth a combined $189K — up 221% from $59K a quarter earlier.

Fund positioning in GENE was balanced in Q1 2024: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $79.5K. The largest seller was UBS Group, cutting an estimated $6.38K.

  • 6 institutional investors held Genetic Technologies Ltd. (GENE) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $189K of Genetic Technologies Ltd. stock for Q1 2024, up 221% quarter-over-quarter.
  • 2 funds opened new Genetic Technologies Ltd. positions in Q1 2024 and 2 closed out, a net change of 0 holders.
  • The largest Genetic Technologies Ltd. buyer in Q1 2024 was Susquehanna International Group, an estimated $79.5K added.
  • The largest Genetic Technologies Ltd. seller in Q1 2024 was UBS Group, an estimated $6.38K sold.

Based on aggregated 13F filings for Q1 2024.